Menu
Your Cart

Wessel Dui F solution for infection. 600LE of amp. 2 ml No. 10

Wessel Dui F solution for infection. 600LE of amp. 2 ml No. 10
Wessel Dui F solution for infection. 600LE of amp. 2 ml No. 10
Wessel Dui F solution for infection. 600LE of amp. 2 ml No. 10
Wessel Dui F solution for infection. 600LE of amp. 2 ml No. 10
Wessel Dui F solution for infection. 600LE of amp. 2 ml No. 10
$105.50
  • Stock: In Stock
  • Model: 184845

0% Customers recommend this product

  • 5 Awesome
    0%
  • 4 Great
    0%
  • 3 Average
    0%
  • 2 Bad
    0%
  • 1 Poor
    0%

Reviews Over Wessel Dui F solution for infection. 600LE of amp. 2 ml No. 10

  • (0)

Total Reviews (0)
click here write review to add review for this product.



Description

Solution for injections Wessel Dui F is shown at:

  • an angiopatiya with the increased risk of thrombosis, including thrombosis after the postponed acute myocardial infarction;
  • cerebrovascular diseases: a stroke (an acute ischemic stroke and the period of early rehabilitation after the had stroke);
  • distsirkulyatorny encephalopathy, the caused atherosclerosis, diabetes, arterial hypertension, and vascular dementia;
  • occlusal diseases of peripheral arteries of both atherosclerotic, and diabetic genesis;
  • a flebopatiya and deep vein thrombosis;
  • a mikroangiopatiya (nephropathy, a retinopathy, neuropathy) and a macrovascular disease (syndrome of diabetic foot, encephalopathy, a cardiopathy) caused by diabetes;
  • a thrombophilia, anti-phospholipidic syndrome;
  • thrombocytopenia heparin.

Structure

Active ingredient: sulodeksid;

1 ampoule (2 ml of solution) contains 600 Leningrad Regions (lipoproteinlipazny units) sulodeksid;

Excipients: sodium chloride, water for injections.

Contraindication

  • Hypersensitivity to active ingredient, heparin and geparinopodibny substances, or to any other components of drug.
  • Hemorrhagic diathesis and diseases which are followed by decrease in blood clotting.

Route of administration

Usually applied schemes of treatment provide parenteral administration of medicament with the subsequent reception of capsules; in certain cases treatment sulodeksidy can be begun directly with reception of capsules. The mode of treatment and the applied doses can be adapted according to the decision of the doctor on the basis of clinical inspection and results of definition of laboratory indicators.

generally capsules is recommended to be accepted in breaks between meal; if the daily dose of capsules is divided into several receptions, it is recommended to maintain a 12-hour interval between reception of doses of drug.

generally the full course of treatment is recommended to repeat

not less than 2 times a year.

Feature of use

Pregnant

As experience of use of medicament in the I trimester of pregnancy is absent, it is necessary to avoid prescribing of medicament to women during this period unless, according to the doctor, the expected advantage of treatment for mother exceeds possible risk for a fruit.

Children

Since 12 years.

Drivers

does not influence.

Overdose

Overdose of medicament can lead

to development of hemorrhagic symptoms, such as hemorrhagic diathesis or bleeding. In case of bleeding it is necessary to enter 1% sulfate protamin solution. Generally at overdose it is necessary to cancel use of medicament and to begin the corresponding symptomatic therapy.

Side effects

  • nausea, vomiting, pains in epigastriums;
  • skin rash (allergic reaction).

Interaction

As sulodeksid is a geparinopodobny molecule, at simultaneous use it can promote growth of anticoagulating effect of heparin and oral anticoagulants. Other clinically significant interactions of medicament with medicines are not revealed.

Storage conditions

to Store

at a temperature not above 30 °C.

to Store

out of children's reach.

Expiration date - 5 years.

Specifications

Characteristics
Active ingredients Sulodeksid
Amount of active ingredient 300 LE/ml
Applicant Alphasigma
Code of automatic telephone exchange B01AB11 Sulodeksid
Interaction with food It doesn't matter
Light sensitivity Not sensitive
Market status Original
Origin Chemical
Prescription status According to the prescription
Primary packing ampoule
Producer S.P.A. ALPHASIGMA.
Quantity in packing 10 ampoules on 2 ml
Release form solution for injections
Route of administration Infusional
Sign Import
Storage temperature from 5 °C to 30 °C
Trade name Wessel